Pro‑Dex announced the completion of its acquisition of Advanced Precision Machining LLC (APM) on February 12, 2026. The transaction, valued at approximately $8.65 million, was finalized on February 9, 2026, and adds a Costa Mesa, California facility to Pro‑Dex’s existing Irvine and Tustin plants.
The deal is financed with a $6.65 million term loan from UMB Bank and a $2 million subordinated seller note, increasing Pro‑Dex’s debt load but providing the capital needed to integrate APM’s operations and support the launch of its next‑generation handpiece and Helios driver products.
APM supplies several of Pro‑Dex’s machined sub‑assemblies and holds ITAR and JCP certifications that are critical for the company’s aerospace, defense, and U.S. government contracts. By bringing APM in‑house, Pro‑Dex gains tighter control over component quality, preserves these certifications, and positions itself to grow APM’s existing business in those sectors while reducing reliance on a single medical‑device OEM that accounted for 75 % of FY2025 revenue.
The acquisition also expands Pro‑Dex’s manufacturing footprint, adding a new production site that will help meet the increased demand from its largest customer following a recent contract extension. Management expects the added capacity to accelerate the rollout of the handpiece and Helios driver lines and to provide operational leverage as volumes rise.
Pro‑Dex’s recent fiscal 2026 second‑quarter results showed earnings per share of $0.66, beating estimates by $0.07, on revenue of $18.66 million. The earnings beat was driven by disciplined cost management and a favorable mix shift toward higher‑margin product lines, offsetting modest inflationary pressure on raw materials. The company’s guidance remains unchanged, reflecting confidence in sustained demand and the integration of APM’s capabilities.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.